253 Anti-TIGIT antibodies require enhanced FcγR co-engagement for optimal T and NK cell-dependent anti-tumor immunity

• Rebecca Ward,
• Elena Paltrinieri,
• Priyadarshini Iyer,
• Sylvia Dietrich,
• Mark Bushell

Affiliations

Rebecca Ward

1Agenus Inc, Lexington, MA, USA

Elena Paltrinieri

2Pyxis Oncology, Cambridge, MA, USA

Priyadarshini Iyer

1Agenus Inc, Lexington, MA, USA

Sylvia Dietrich

3Dragonfly Therapeutics Inc, Waltham, MA, USA

Mark Bushell

1Agenus Inc, Lexington, MA, USA